< Back to Article

Dose optimization of an adjuvanted peptide-based personalized neoantigen melanoma vaccine

Table 4

Clinical response using J₂.

Optimal vaccine dose performance using overall and individual ratios for J₂ together with total vaccine dose ratio when compared to clinical trial dose. Green cells indicate more clinical benefit or a lower total vaccine dose. Red cells indicate less clinical benefit or a higher total vaccine dose.

doi: https://doi.org/10.1371/journal.pcbi.1011247.t004